港股午評:恆指跌1.5% 恆生科技指數跌近2% 內房股暴漲
格隆匯11月9日丨港股走勢震盪,尾盤跌幅擴大,三大指數午間集體收跌,恆指跌1.52%,國指跌1.4%,恆生科技指數跌1.92%。 南下資金半日淨流入24.02億港元,大市成交額爲629億港元。 盤面上,權重科技股受壓,嗶哩嗶哩跌6%、百度、美團跌逾4%,京東、騰訊跌3%。汽車股繼續下跌,遭巴菲特減持的比亞迪跌5%;近日漲幅強勢的生物技術股普跌,藥明生物跌5%;手遊股、雲計算股、菸草股、餐飲股、體育用品多等股普跌。另一方面,房企融資環境正在好轉,內房股和物管股集體大漲,帶動建材水泥股回暖,旭輝控股集團漲近34%,龍光集團漲逾28%;隔夜黃金漲超2%升破1710美元,黃金股上揚;風電股、鋁股、電力股、半導體股等股走強。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.